RAMELTEON
Generic: RAMELTEON
Micro Labs LimitedManufacturer
ORALRoute
RAMELTEONActive Substance
2023-02-09Original Approval
RAMELTEON is FDA application ANDA215243, sponsored by MICRO LABS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
79 reports
2
OFF LABEL USE
70 reports
3
NAUSEA
67 reports
4
DECREASED APPETITE
64 reports
5
DIARRHOEA
63 reports
6
INSOMNIA
60 reports
7
FATIGUE
53 reports
8
PNEUMONIA
52 reports
9
FALL
48 reports
10
VOMITING
45 reports